The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins

Mature spermatozoa are almost completely devoid of cytoplasm; as such it has long been believed that they do not contain ribosomes and are therefore not capable of synthesising proteins. However, since the 1950s, various studies have shown translational activity within spermatozoa, particularly duri...

Full description

Bibliographic Details
Main Authors: Marie Bisconti, Baptiste Leroy, Meurig T. Gallagher, Coralie Senet, Baptiste Martinet, Vanessa Arcolia, Ruddy Wattiez, Jackson C. Kirkman-Brown, Jean-François Simon, Elise Hennebert
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.965076/full
_version_ 1828136932825104384
author Marie Bisconti
Baptiste Leroy
Meurig T. Gallagher
Coralie Senet
Baptiste Martinet
Vanessa Arcolia
Ruddy Wattiez
Jackson C. Kirkman-Brown
Jean-François Simon
Elise Hennebert
author_facet Marie Bisconti
Baptiste Leroy
Meurig T. Gallagher
Coralie Senet
Baptiste Martinet
Vanessa Arcolia
Ruddy Wattiez
Jackson C. Kirkman-Brown
Jean-François Simon
Elise Hennebert
author_sort Marie Bisconti
collection DOAJ
description Mature spermatozoa are almost completely devoid of cytoplasm; as such it has long been believed that they do not contain ribosomes and are therefore not capable of synthesising proteins. However, since the 1950s, various studies have shown translational activity within spermatozoa, particularly during their in vitro capacitation. But the type of ribosomes involved (cytoplasmic or mitochondrial) is still debated. Here, we investigate the presence and activity of the two types of ribosomes in mature human spermatozoa. By targeting ribosomal RNAs and proteins, we show that both types of ribosomes are localized in the midpiece as well as in the neck and the base of the head of the spermatozoa. We assessed the impact of cycloheximide (CHX) and chloramphenicol (CP), inhibitors of cytoplasmic and mitochondrial ribosomes, respectively, on different sperm parameters. Neither CHX, nor CP impacted sperm vitality, mitochondrial activity (measured through the ATP content), or capacitation (measured through the content in phosphotyrosines). However, increasing CP concentrations induced a decrease in total and progressive motilities as well as on some kinematic parameters while no effect was observed with CHX. A quantitative proteomic analysis was performed by mass spectrometry in SWATH mode to compare the proteomes of spermatozoa capacitated in the absence or presence of the two ribosome inhibitors. Among the ∼700 proteins identified in the different tested conditions, 3, 3 and 25 proteins presented a modified abundance in the presence of 1 and 2 mg/ml of CHX, and 1 mg/ml of CP, respectively. The observed abundance variations of some CP-down regulated proteins were validated using Multiple-Reaction Monitoring (MRM). Taken together, our results are in favor of an activity of mitochondrial ribosomes. Their inhibition by CP results in a decrease in the abundance of several proteins, at least FUNDC2 and QRICH2, and consequently induces sperm motility deficits.
first_indexed 2024-04-11T18:12:47Z
format Article
id doaj.art-2e11178de0ae4aa88a86efecc5cfeded
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-11T18:12:47Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-2e11178de0ae4aa88a86efecc5cfeded2022-12-22T04:10:04ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-09-011010.3389/fcell.2022.965076965076The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteinsMarie Bisconti0Baptiste Leroy1Meurig T. Gallagher2Coralie Senet3Baptiste Martinet4Vanessa Arcolia5Ruddy Wattiez6Jackson C. Kirkman-Brown7Jean-François Simon8Elise Hennebert9Laboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Mons, BelgiumLaboratory of Proteomics and Microbiology, CISMa, Research Institute for Biosciences, University of Mons, Mons, BelgiumCentre for Systems Modelling and Quantitative Biomedicine, University of Birmingham, Centre for Human Reproductive Science, Birmingham Women’s and Children’s National Health Service Foundation Trust, Birmingham, United KingdomLaboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Mons, BelgiumEvolutionary Biology and Ecology, Université Libre de Bruxelles, Brussels, BelgiumClinique de Fertilité Régionale de Mons, CHU Ambroise Paré Hospital, Mons, BelgiumLaboratory of Proteomics and Microbiology, CISMa, Research Institute for Biosciences, University of Mons, Mons, BelgiumInstitute of Metabolism and Systems Research, University of Birmingham, Centre for Human Reproductive Science, Birmingham Women’s and Children’s National Health Service Foundation Trust, Birmingham, United KingdomClinique de Fertilité Régionale de Mons, CHU Ambroise Paré Hospital, Mons, BelgiumLaboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Mons, BelgiumMature spermatozoa are almost completely devoid of cytoplasm; as such it has long been believed that they do not contain ribosomes and are therefore not capable of synthesising proteins. However, since the 1950s, various studies have shown translational activity within spermatozoa, particularly during their in vitro capacitation. But the type of ribosomes involved (cytoplasmic or mitochondrial) is still debated. Here, we investigate the presence and activity of the two types of ribosomes in mature human spermatozoa. By targeting ribosomal RNAs and proteins, we show that both types of ribosomes are localized in the midpiece as well as in the neck and the base of the head of the spermatozoa. We assessed the impact of cycloheximide (CHX) and chloramphenicol (CP), inhibitors of cytoplasmic and mitochondrial ribosomes, respectively, on different sperm parameters. Neither CHX, nor CP impacted sperm vitality, mitochondrial activity (measured through the ATP content), or capacitation (measured through the content in phosphotyrosines). However, increasing CP concentrations induced a decrease in total and progressive motilities as well as on some kinematic parameters while no effect was observed with CHX. A quantitative proteomic analysis was performed by mass spectrometry in SWATH mode to compare the proteomes of spermatozoa capacitated in the absence or presence of the two ribosome inhibitors. Among the ∼700 proteins identified in the different tested conditions, 3, 3 and 25 proteins presented a modified abundance in the presence of 1 and 2 mg/ml of CHX, and 1 mg/ml of CP, respectively. The observed abundance variations of some CP-down regulated proteins were validated using Multiple-Reaction Monitoring (MRM). Taken together, our results are in favor of an activity of mitochondrial ribosomes. Their inhibition by CP results in a decrease in the abundance of several proteins, at least FUNDC2 and QRICH2, and consequently induces sperm motility deficits.https://www.frontiersin.org/articles/10.3389/fcell.2022.965076/fullhuman spermatozoacapacitationribosomecycloheximidechoramphenicolsperm parameters
spellingShingle Marie Bisconti
Baptiste Leroy
Meurig T. Gallagher
Coralie Senet
Baptiste Martinet
Vanessa Arcolia
Ruddy Wattiez
Jackson C. Kirkman-Brown
Jean-François Simon
Elise Hennebert
The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins
Frontiers in Cell and Developmental Biology
human spermatozoa
capacitation
ribosome
cycloheximide
choramphenicol
sperm parameters
title The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins
title_full The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins
title_fullStr The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins
title_full_unstemmed The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins
title_short The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins
title_sort ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa a proteomic approach identifies potentially involved proteins
topic human spermatozoa
capacitation
ribosome
cycloheximide
choramphenicol
sperm parameters
url https://www.frontiersin.org/articles/10.3389/fcell.2022.965076/full
work_keys_str_mv AT mariebisconti theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT baptisteleroy theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT meurigtgallagher theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT coraliesenet theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT baptistemartinet theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT vanessaarcolia theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT ruddywattiez theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT jacksonckirkmanbrown theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT jeanfrancoissimon theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT elisehennebert theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT mariebisconti ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT baptisteleroy ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT meurigtgallagher ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT coraliesenet ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT baptistemartinet ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT vanessaarcolia ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT ruddywattiez ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT jacksonckirkmanbrown ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT jeanfrancoissimon ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins
AT elisehennebert ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins